Shaina Bruce, MD

Gynecologic Oncology Fellow ‘23 @WashU_ObGyn.

[Katherine Fuh MD PhD @KatherineFuh]

Congrats @sbrucemd on such great work!! Can’t wait to see this through as a clinical trial. Collaborating with the fab metabophile @gjpattij was pretty fun too. Thanks @MCT_AACR for the featured article!

[Shaina Bruce, MD @sbrucemd]

I’m so grateful for @KatherineFuh’s amazing mentorship! Thesis ✅ And my first featured article! @MCT_AACR @WashU_OBGYN https://t.co/qJcYu0dPoU

[Shannon Westin, MD, MPH, FASCO @ShannonWestin]

Molecular testing is absolutely the standard of care for #EndometrialCancer! @matthewapowell breaks down an incredible number of abstracts supporting this paradigm at #SGOMtg #BreakingBarriers #gyncsm

[Andrea Hagemann, MD, MSCI @AndreaHagemann]

Kudos to @SGO_org #SGOMtg for today’s #GenderEquity session. Let’s keep these very hard and very real conversations—and actions by leadership and societies—going. @WashU_OBGYN #ILookLikeASurgeon

[Andrea Hagemann, MD, MSCI @AndreaHagemann]

Congrats, @sbrucemd, on a fabulous @SGO_org talk! New patient #gynonc visits @WashU_OBGYN down during covid due to well known social determinants of health. Patient navigators, education/outreach and using community resources can help close gaps. I hope @WarnerHuhSGO is right.

[Andrea Hagemann, MD, MSCI @AndreaHagemann]

Congrats, @Fuh_Lab! Your translational work is elevating and transforming ovarian cancer care! @WashU_OBGYN #SGOMtg @SGO_org

[NEJM @NEJM]

In women with advanced endometrial cancer, the median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months and 11.4 months, respectively. https://t.co/lzqFDnhAQn

[1001cuts - the film @1001cuts]

The surgeon's voice - is it too loud? Or not loud enough? How finding the right tenor and tone can be a challenge for #surgeonswhoarewomen. #1001cuts #ILookLikeASurgeon.

[Shaina Bruce, MD @sbrucemd]

How tumor board gets done these days! 👶

[NRG Oncology @NRGonc]

PRESS RELEASE: NRG Oncology Trial Data Concludes Paclitaxel and Carboplatin Should be Considered the Standard of Care as First-line Treatment for Women with Uterine Carcinosarcoma https://t.co/yZrUg6Dpgt @WUSTL #GYN #gyncsm #uterinecancer

[Shaina Bruce, MD @sbrucemd]

Excited to share my work exploring the impact of the COVID-19 pandemic on referral to and delivery of gyn-onc care! ⁦@WashU_OBGYN⁩ https://t.co/gbFbYehtsH

[RSDPScholars @RsdpScholars]

NEW PUBLICATION!
RSDP Scholar: Dr. Maggie Mullen.

[Nan Raghuraman MD MSCI @NanRaghuraman]

On service today at @WashU_OBGYN @BarnesJewish and the number of pregnant covid cases is unbelievable. Nonstop transfers, admissions, and positive covid tests. Missouri, there is no better time to get #vaccinated and no better time to believe in science.

[Shaina Bruce, MD @sbrucemd]

Women Surgeons at Greater Risk of Pregnancy Loss, Study Finds https://t.co/ffYTgOIACu

[Shaina Bruce, MD @sbrucemd]

A great read about a very sad story. #hahnemann https://t.co/SuFSdRA5wN

[Shaina Bruce, MD @sbrucemd]

This. https://t.co/pvzdKxaLKp

[Shaina Bruce, MD @sbrucemd]

So excited to virtually attend the @SGO_org 2021 Minimally Invasive Surgery Workshop!

[Shaina Bruce, MD @sbrucemd]

@SarahAckroydMD @AJOG_thegray I also wonder this haha

[Sarah Ackroyd @SarahAckroydMD]

@SGO_org #SGOMtg promoting its commitment to gender equity in our mission statement. Thanks to these leaders for empowering us. And all three upcoming sgo presidents represented!! @sd_yamada @StephanieVBlank @heidigraydrezn5 @AngelesSecord